This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Novartis Ag. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2008
Title: Esteban Pombo Villar: Innovator in Pharmaceutical Chemistry
Introduction
Esteban Pombo Villar is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a focus on treating eye conditions, his work has garnered attention in the scientific community.
Latest Patents
Esteban Pombo Villar holds 2 patents related to quinoline derivatives. His latest patents include innovations that pertain to novel benzo [g] quinoline derivatives, which are designed for use in the treatment of glaucoma and myopia. The first patent details the preparation and pharmaceutical applications of these compounds. The second patent provides a specific compound formula, wherein A, B, X, Y, and R are defined, along with a process for their preparation. These compounds are recognized for their potential as effective pharmaceuticals.
Career Highlights
Throughout his career, Esteban has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Rudolf Markstein. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.
Collaborations
Esteban has collaborated with notable professionals in his field, including Peter Gull and Rudolf Markstein. These partnerships have facilitated the exchange of ideas and fostered innovation in pharmaceutical research.
Conclusion
Esteban Pombo Villar is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in the treatment of eye conditions. His patents and collaborations reflect his commitment to improving healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
